Provided by Tiger Trade Technology Pte. Ltd.

Jaguar Animal Health

3.66
-0.2900-7.34%
Post-market: 3.660.0015+0.04%18:51 EDT
Volume:594.31K
Turnover:2.31M
Market Cap:18.92M
PE:0.00
High:4.30
Open:4.15
Low:3.50
Close:3.95
52wk High:1,152.61
52wk Low:2.35
Shares:5.17M
Float Shares:331.09K
Volume Ratio:0.09
T/O Rate:179.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2,338.1604
EPS(LYR):-12,059.1987
ROE:-548.83%
ROA:-38.04%
PB:2.86
PE(LYR):0.00

Loading ...

Jaguar Animal Health Faces New Nasdaq Compliance Deficiency

TIPRANKS
·
May 04

Jaguar Health risks Nasdaq delisting after reverse split cuts public float below 500,000 shares

Reuters
·
May 04

Jaguar Animal Health trading halted, news pending

TIPRANKS
·
Apr 30

Jaguar Health announces results from trial of crofelemer

TIPRANKS
·
Apr 29

Jaguar Health says crofelemer trial meets primary endpoint in dogs with chemotherapy-induced diarrhea

Reuters
·
Apr 29

Jaguar Health granted extension to demonstrate compliance with Nasdaq bid rule

TIPRANKS
·
Apr 27

Jaguar Health executes 1-for-35 reverse stock split effective April 30

Reuters
·
Apr 27

Jaguar Health reports acceptance of abstracts on crofelemer for ESPGHAN meeting

TIPRANKS
·
Apr 24

Jaguar Health says two late-breaking pediatric intestinal failure crofelemer abstracts accepted at ESPGHAN

Reuters
·
Apr 24

Jaguar Health plans AI platforms to advance crofelemer clinical development for intestinal failure

Reuters
·
Apr 13

Jaguar Health hosts investor webcast on Q4 2025 financials and company updates

Reuters
·
Apr 10

Jaguar Animal Health Regains Nasdaq Compliance Through Capital Infusions

TIPRANKS
·
Apr 10

Jaguar Health completes effectiveness study of crofelemer tablets

TIPRANKS
·
Apr 08

Jaguar Health completes dog trial to support full FDA approval for Canalevia-CA1

Reuters
·
Apr 08

Jaguar Health FY25 net loss widens 37.6% to $54 million

Reuters
·
Apr 07

Jaguar Health says crofelemer study cuts pediatric intestinal failure parenteral support 12%-37%

Reuters
·
Apr 02

Jaguar Health unit Napo co-sponsors Elite Ped-GI Congress, spotlights crofelemer pediatric IF data

Reuters
·
Apr 02